2308506-A1 cites 13 patents.

The invention relates to adjuvanted vaccine formulations, in particular influenza vaccines for intranasal delivery. Provided is an adjuvanted influenza vaccine formulation, comprising (i) peptidoglycan microparticles obtained from a Gram-positive bacterium and (ii) at least one influenza virus antigen or antigenic preparation thereof, which antigen or antigenic preparation is not fused or otherwise covalently attached to a proteinaceous peptidoglycan binding moiety.

Title
Adjuvanted intranasal vaccine formulations
Intranasale Adjuvansimpfstoffformulierungen
Formulations de vaccin intranasal avec adjuvants
Application Number
EP20090172099 20091002
Publication Number
2308506 (A1)
Application Date
October 2, 2009
Publication Date
April 13, 2011
Inventor
LEENHOUTS CORNELIS JOHANNES
NL
SCHOUTEN GOVERT JOHAN
NL
Assignee
MUCOSIS
NL
IPC
A61K 39/145
View Original Source Download PDF